DocDollars

Kerecis Limited

Iceland · Reporting entity ID 100000151666

Total reported 2019–2025
$16.4M
#361 of 2,960 reporting companies — 0% of all reported industry payments
$14.4M in general payments across 54,016 records, plus $815K in research funding across 82 records.

How it breaks down

General payments $14,446,970
Research funding $814,515
Ownership & investment $1,142,538

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Kerecis Limited reported $16.4M to US doctors and teaching hospitals from 2019 to 2025, ranking #361 of 2,960 reporting companies. 5% of that was research funding and 95% general payments such as consulting, speaking, food and travel. 54,016 general payment records and 82 research records were filed.

Common questions about Kerecis Limited

How much has Kerecis Limited paid US doctors?

Kerecis Limited reported $16,404,022 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $14,446,970 in general payments, $814,515 in research funding and $1,142,538 in ownership and investment interests.

How does Kerecis Limited rank among drug and device companies?

It ranks #361 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Kerecis Limited mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.